AdvaMed has criticized a 2020 Medicare Outpatient Prospective Payment System (OPPS) proposal mandating that hospitals publicly post prices for their 300 most-frequently used procedure costs and lab tests.
The medtech industry advocacy group commented that the transparency plan laid out in the draft OPPS rule issued by the US Centers for Medicare and Medicaid Services (CMS) could...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?